Journal of the Neurological Sciences
Volume 226, Issue 1 , Pages 19-23 , 15 November 2004

Vascular factors in dementia: an overview

References 

  1. Hebert LE, Beckett LA, Scherr PA, Evans DA. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis. Assoc. Disord. 2001;15(4):169–173
  2. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA. 1989;262(18):2551–2556
  3. Sayetta RB. Rates of senile dementia, Alzheimer's type, in the Baltimore longitudinal study. J. Chronic. Dis. 1986;39(4):271–286
  4. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham study. Stroke. 1991;22(3):312–318
  5. Mungas D, Reed B, Ellis WG, Jagust WJ. The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Arch. Neurol. 2001;58:1243–1247
  6. Chui H. Dementia due to subcortical ischemic vascular disease. Clin. Cornerstone. 2001;3(4):40–51
  7. Chui HC, Mack W, Jackson JE, Mungas D, Reed BR, Tinklenberg J, et al. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. Arch. Neurol. 2000;57(2):191–196
  8. Chui H. Vascular dementia, a new beginning: shifting focus from clinical phenotype to ischemic brain injury. Neurol. Clin. 2000;18(4):951–978
  9. Wu CC, Mungas D, Petkov CI, Eberling JL, Zrelak PA, Buonocore MH, et al. Brain structure and cognition in a community sample of elderly Latinos. Neurology. 2002;59(3):383–391
  10. Slooter AJ, van Duijn CM, Bots ML, Ott A, Breteler MB, De Voecht J, et al. Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam Study. J. Neural Transm. Suppl. 1998;53:17–29
  11. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, et al. Midlife blood pressure and dementia: the Honolulu–Asia aging study. Neurobiol. Aging. 2000;21(1):49–55
  12. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347(9009):1141–1145
  13. Kivipelto M, Helkala EL, Hanninen T, Laakso MP, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology. 2001;56(12):1683–1689
  14. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001;322(7300):1447–1451
  15. Kivipelto M, Laakso MP, Toumilehto J, Nissinen A, Soininen H. Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention. CNS Drugs. 2002;16(7):435–444
  16. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N. Engl. J. Med. 2003;348(13):1215–1222
  17. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 2002;346(7):476–483
  18. Weber MA. Role of hypertension in coronary artery disease. Am. J. Nephrol. 1996;16(3):210–216
  19. Gillum RF. Coronary heart disease, stroke, and hypertension in a U.S. national cohort: the NHANES I Epidemiologic follow-up study. National health and nutrition examination survey. Ann. Epidemiol. 1996;6(4):259–262
  20. Zheng ZJ, Sharrett AR, Chambless LE, Rosamond WD, Nieto FJ, Sheps DS, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk In Communities (ARIC) study. Atherosclerosis. 1997;131(1):115–125
  21. Papademetriou V, Narayan P, Rubins H, Collins D, Robins S. Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levels. HIT Investigators. Department of Veterans Affairs HDL Intervention Trial. Am. Heart J. 1998;136(4 Pt 1):734–740
  22. Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation. 2000;102(25):3137–3147
  23. Antikainen R, Jousilahti P, Tuomilehto J. Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population. J. Hypertens. 1998;16(5):577–583
  24. Boon A, Lodder J, Heuts-van Raak L, Kessels F. Silent brain infarcts in 755 consecutive patients with a first-ever supratentorial ischemic stroke. Relationship with index-stroke subtype, vascular risk factors, and mortality. Stroke. 1994;25(12):2384–2390
  25. Brott T, Tomsick T, Feinberg W, Johnson C, Biller J, Broderick J, et al. Baseline silent cerebral infarction in the asymptomatic carotid atherosclerosis study. Stroke. 1994;25(6):1122–1129
  26. Ezekowitz MD, James KE, Nazarian SM, Davenport J, Broderick JP, Gupta SR, et al. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Circulation. 1995;92(8):2178–2182
  27. Jørgensen HS, Nakayama H, Raaschou HO, Gam J, Olsen TS. Silent infarction in acute stroke patients. Prevalence, localization, risk factors, and clinical significance: the Copenhagen stroke study [see comments]. Stroke. 1994;25(1):97–104
  28. Kase CS, Wolf PA, Chodosh EH, Zacker HB, Kelly-Hayes M, Kannel WB, et al. Prevalence of silent stroke in patients presenting with initial stroke: the Framingham study. Stroke. 1989;20(7):850–852
  29. Shinkawa A, Ueda K, Kiyohara Y, Kato I, Sueishi K, Tsuneyoshi M, et al. Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study. Stroke. 1995;26(3):380–385
  30. Steingart A, Lau K, Fox A, Diaz F, Fisman M, Hachinski V, et al. The significance of white matter lucencies on CT scan in relation to cognitive impairment. Can. J. Neurol. Sci. 1986;13(4 Suppl.):383–384
  31. Hachinski VC, Potter P, Merskey H. Leuko-araiosis: an ancient term for a new problem. Can. J. Neurol. Sci. 1986;13(4 Suppl.):533–534
  32. Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch. Neurol. 1987;44(1):21–23
  33. Steingart A, Hachinski VC, Lau C, Fox AJ, Diaz F, Cape R, et al. Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch. Neurol. 1987;44(1):32–35
  34. Steingart A, Hachinski VC, Lau C, Fox AJ, Fox H, Lee D, et al. Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch. Neurol. 1987;44(1):36–39
  35. Yue NC, Arnold AM, Longstreth WT, Elster AD, Jungreis CA, O'Leary DH, et al. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study [see comments]. Radiology. 1997;202(1):33–39
  36. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: the Rotterdam study [see comments]. Neurology. 1999;53(9):1937–1942
  37. Manolio TA, Kronmal RA, Burke Gl, et al. Magnetic resonance abnormalities and cardiovascular disease in older adults: the cardiovascular health study. Stroke. 1994;25:318–327
  38. Liao D, Cooper L, Cai J, Toole JF, Bryan NR, Hutchinson RG, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC study. Atherosclerosis risk in communities study. Stroke. 1996;27(12):2262–2270
  39. Liao D, Cooper L, Cai J, Toole J, Bryan N, Burke G, et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology. 1997;16(3):149–162
  40. Swan GE, DeCarli C, Miller BL, Reed T, Wolf PA, Jack LM, et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology. 1998;51(4):986–993
  41. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Garner J, et al. Predictors of brain morphology for the men of the NHLBI twin study. Stroke. 1999;30(3):529–536
  42. Miyao S, Takano A, Teramoto J, Takahashi A. Leukoaraiosis in relation to prognosis for patients with lacunar infarction. Stroke. 1992;23(10):1434–1438
  43. Streifler JY, Eliasziw M, Fox AJ, et al. Prognostic importance of leukoaraiosis in patients with ischemic events and carotid artery disease. Stroke. 1999;30:254
  44. Manolio TA, Burke GL, O'Leary DH, Evans G, Beauchamp N, Knepper L, et al. Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the cardiovascular health study. CHS collaborative research group. Arterioscler. Thromb. Vasc. Biol. 1999;19(2):356–365
  45. de Leeuw FE, Cees De Groot J, Oudkerk M, Witteman JC, Hofman A, van Gijn J, et al. Aortic atherosclerosis at middle age predicts cerebral white matter lesions in the elderly. Stroke. 2000;31(2):425–429
  46. Salerno JA, Murphy DG, Horwitz B, DeCarli C, Haxby JV, Rapoport SI, et al. Brain atrophy in hypertension. A volumetric magnetic resonance imaging study. Hypertension. 1992;20(3):340–348
  47. Strassburger TL, Lee HC, Daly EM, Szczepanik J, Krasuski JS, Mentis MJ, et al. Interactive effects of age and hypertension on volumes of brain structures. Stroke. 1997;28(7):1410–1417
  48. Swan GE, DeCarli C, Miller BL, Reed T, Wolf PA, Carmelli D. Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy. Neurology. 2000;54(11):2108–2114
  49. Gesztelyi G, Finnegan W, DeMaro JA, Wang JY, Chen JL, Fenstermacher J. Parenchymal microvascular systems and cerebral atrophy in spontaneously hypertensive rats. Brain Res. 1993;611(2):249–257
  50. Tajima A, Hans FJ, Livingstone D, Wei L, Finnegan W, DeMaro J, et al. Smaller local brain volumes and cerebral atrophy in spontaneously hypertensive rats. Hypertension. 1993;21(1):105–111
  51. Mentis MJ, Salerno J, Horwitz B, Grady C, Schapiro MB, Murphy DG, et al. Reduction of functional neuronal connectivity in long-term treated hypertension. Stroke. 1994;25(3):601–607
  52. Price JL, Morris JC. Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease. Ann. Neurol. 1999;45(3):358–368
  53. Morris JC, Price AL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J. Mol. Neurosci. 2001;17(2):101–118
  54. Seshadri S, Wolf PA, Beiser A, Elias MF, Au R, Kase CS, et al. Stroke risk profile predicts brain volume and cognitive function in stroke-free subjects: the Framingham study. Stroke. 2001;32(1):321-c
  55. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham study. Stroke. 1994;25(1):40–43
  56. Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56(1):42–48
  57. Morris MC, Scherr PA, Hebert LE, Bennett DA, Wilson RS, Glynn RJ, et al. Association between blood pressure and cognitive function in a biracial community population of older persons. Neuroepidemiology. 2002;21(3):123–130
  58. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun study. JAMA. 1997;277:813–817
  59. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, et al. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to establish a registry for Alzheimer's disease. Neurology. 1998;51:159–162
  60. Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J. Neurol. Neurosurg. Psychiatry. 1997;63(6):749–753
  61. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, et al. The effects of additional pathology on the cognitive deficit in Alzheimer disease. J. Neuropathol. Exp. Neurol. 1997;56(2):165–170
  62. Schneider JA, Wilson RS, Cochran EJ, Bienias JL, Arnold SE, Evans DA, et al. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology. 2003;60(7):1082–1088
  63. Lee JH, Olichney JM, Hansen LA, Hofstetter CR, Thal LJ. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch. Neurol. 2000;57(10):1474–1479
  64. Lafosse JM, Reed BR, Mungas D, Sterling SB, Wahbeh H, Jagust WJ. Fluency and memory differences between ischemic vascular dementia and Alzheimer's disease. Neuropsychology. 1997;11(4):514–522
  65. Wolfe N, Linn R, Babikian VL, Knoefel JE, Albert ML. Frontal systems impairment following multiple lacunar infarcts. Arch. Neurol. 1990;47(2):129–132
  66. Cummings JL, Miller B, Hill MA, Neshkes R. Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type. Arch. Neurol. 1987;44(4):389–393
  67. Tatemichi TK, Desmond DW, Prohovnik I. Strategic infarcts in vascular dementia. a clinical and brain imaging experience. Arzneimittel-Forschung. 1995;45(3A):371–385
  68. Tatemichi TK, Desmond DW, Prohovnik I, Cross DT, Gropen TI, Mohr JP, et al. Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome?. Neurology. 1992;42(10):1966–1979
  69. Reed BR, Eberling JL, Mungas D, Weiner MW, Jagust WJ. Memory failure has different mechanisms in subcortical stroke and Alzheimer's disease. Ann. Neurol. 2000;48(3):275–284
  70. Elias MF, Wolf PA, D'Agostino RB, Cobb J, White LR. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham study. Am. J. Epidemiol. 1993;138:353–364
  71. Elias PK, D'Agostino RB, Elias MF, Wolf PA. Blood pressure, hypertension, and age as risk factors for poor cognitive performance. Exp. Aging Res. 1995;21(4):393–417
  72. Elias PK, Elias MF, D'Agostino RB, Cupples LA, Wilson PW, Silbershatz H, et al. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham study. Diabetes Care. 1997;20(9):1388–1395
  73. Elias MF, Robbins MA, Elias PK, Streeten DH. A longitudinal study of blood pressure in relation to performance on the Wechsler adult intelligence scale. Health Psychol. 1998;17(6):486–493
  74. Elias MF. Effects of chronic hypertension on cognitive functioning. Geriatrics. 1998;53(Suppl 1(6)):S49–S52
  75. Launer LJ, Masaki K, Petrovich H, Foley D, Havlik RJ. The association between mid-life blood pressure levels and late-life cognitive function. The Honolulu–Asia aging study. JAMA. 1995;274:1846–1851
  76. Swan GE, Carmelli D, LaRue A. Relationship between blood pressure during middle age and cognitive impairment in old age: the Western Collaborative group study. Aging Neuropsychol. Cognition. 1996;3:241–250
  77. Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM, Van Broeckhoven C, et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam study. Arch. Neurol. 1998;55(7):964–988
  78. DeCarli C, Reed T, Miller BL, Wolf PA, Swan GE, Carmelli D. Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study. Stroke. 1999;30(8):1548–1553
  79. Laskowitz DT, Sheng H, Bart RD, Joyner KA, Roses AD, Warner DS. Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia. J. Cereb. Blood Flow Metab. 1997;17(7):753–758
  80. Ukkola O, Kervinen K, Salmela PI, von Dickhoff K, Laakso M, Kesaniemi YA. Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis. 1993;101(1):9–15
  81. Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam study. Lancet. 1998;351(9119):1840–1843
  82. Dufouil C, Tzourio C, Brayne C, Berr C, Amouyel P, Alperovitch A. Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers. Epidemiology. 2000;11(3):280–284
  83. Carmelli D, Swan GE, Reed T, Schellenberg GD, Christian JC. The effect of apolipoprotein E epsilon4 in the relationships of smoking and drinking to cognitive function. Neuroepidemiology. 1999;18(3):125–133
  84. Carmelli D, Swan GE, Reed T, Miller B, Wolf PA, Jarvik GP, et al. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology. 1998;50(6):1580–1585
  85. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA. 1999;282(1):40–46
  86. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study [see comments]. Lancet. 1997;349(9046):151–154
  87. Sparks DL, Scheff SW, Liu H, Landers TM, Coyne CM, Hunsaker JC. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J. Neurol. Sci. 1995;131(2):162–169
  88. Sparks DL. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease?. Ann. N.Y. Acad. Sci. 1997;826:128–146
  89. Sparks DL, Martin TA, Gross DR, Hunsaker JC. Link between heart disease, cholesterol, and Alzheimer's disease: a review. Microsc. Res. Tech. 2000;50(4):287–290
  90. Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu–Asia aging study. Neurobiol. Aging. 2000;21(1):57–62

PII: S0022-510X(04)00286-2

doi: 10.1016/j.jns.2004.09.005

Journal of the Neurological Sciences
Volume 226, Issue 1 , Pages 19-23 , 15 November 2004

Article Tools